跳至主要内容
临床试验/NCT00569374
NCT00569374已完成2 期

Safety and Tolerability of Modafinil for Methamphetamine Dependence

University of Arkansas2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2007年9月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
8
试验地点
2
主要终点
Heart Rate

研究概览

简要总结

This 7 week, open-label pilot clinical trial will examine the safety and tolerability of modafinil up to 400mg/day as a potential treatment to reduce methamphetamine use in methamphetamine-dependent volunteers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-65 years old
  • not currently enrolled in a treatment program
  • subjects must have a history of methamphetamine use with recent use confirmed by a positive urine toxicology screen for amphetamines during the month prior to study entry
  • subjects must meet DSM-IV criteria for amphetamine dependence as assessed by the substance abuse section of the Structured Clinical Interview for DSM-IV (SCID)
  • women of childbearing age must have a negative pregnancy test to enroll in this study, agree to monthly pregnancy testing, and agree to use appropriate forms of birth control for the duration of the study

排除标准

  • current diagnosis of alcohol, opiate, or sedative physical dependence
  • ill health (e.g., major cardiovascular, renal, endocrine, hepatic disorder)
  • history of schizophrenia, or bipolar type I disorder
  • present or recent use of over-the-counter or prescription psychoactive drug or drug(s) that would be expected to have major interaction with drug to be tested
  • medical contraindication to receiving study medications (e.g., allergy to modafinil, treatment with cyclosporine, clomipramine, or desipramine)
  • Current suicidality or psychosis
  • liver function tests (i.e., liver enzymes) greater than three times normal levels
  • pregnancy or breastfeeding

结局指标

主要结局

Heart Rate

时间窗: Thrice weekly for 7 weeks

Heart rate as a safety measure was measured by thrice weekly measuring heart rate in beats per minute.

Systolic Blood Pressure

时间窗: Thrice weekly for 7 weeks

Systolic blood pressure as a safety measure was measured by thrice weekly measuring blood pressure in mmHg.

Diastolic Blood Pressure

时间窗: Thrice weekly for 7 weeks

Diastolic blood pressure as a safety measure was measured by thrice weekly measuring blood pressure in mmHg.

"Modafinil Side Effects Checklist"

时间窗: Weekly for 7 weeks

Modafinil side effects were measured weekly by means of the Modafinil Side Effects Checklist which asked participants to rate their experience of the following potential side effects: headaches, nausea, nervousness, runny nose, diarrhea, back pain, anxiety, insomnia, dizziness and upset stomach. Participants rated their experience on a 4 point scale ranging from "not at all" (0) to "very much (4). The score was determined by units on a scale.

Anxiety as Measured by the Hamilton Anxiety Scale

时间窗: Thrice weekly for 7 weeks

Participants were administered the Hamilton Anxiety Scale thrice weekly throughout the study. The scale is a 14 item questionaire with scores ranging from 0 to 56.

Depression as Measured by the Hamilton Depression Scale

时间窗: Thrice weekly for 7 weeks

Participants were administered the Hamilton Depression Scale thrice weekly throughout the study. The scale is a 21 item questionaire with scores ranging from 0 to 62 with a cutoff for depression of 15.

次要结局

  • Methamphetamine Withdrawal as Measured Using the Amphetamine Withdrawal Questionaire.(Thrice weekly for the first three weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验